GlassScriptPhysician profile
Shi Tze Lu
NPI 1215932900
$3,761.53
in general payments reported to CMS, 2019-2025
36 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $712 · 2021: $603 · 2022: $428 · 2023: $361 · 2024: $145 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $561.93 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $403.76 | 2019-2022 | |
| Astellas Pharma US INC | $390.12 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $259.27 | 2019-2022 | |
| Abbott Laboratories | $198.76 | 2019-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $195.00 | 2019-2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $154.58 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $137.65 | 2019-2021 | |
| Glaxosmithkline, LLC. | $135.57 | 2019-2024 | Shingrix, Arexvy |
| Vanda Pharmaceuticals INC. | $133.56 | 2019-2023 | Hetlioz |
| Abbvie INC. | $121.04 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.64 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $101.13 | 2019-2021 | |
| Intuitive Surgical, INC. | $98.00 | 2020 | |
| Dexcom, INC. | $86.54 | 2024-2025 | Dexcom G6 Transmitter |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $74.81 | 2023-2025 | Inspire |
| Allergan, INC. | $67.90 | 2019-2020 | |
| Gilead Sciences, INC. | $64.90 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.80 | 2019-2021 | |
| Pfizer INC. | $50.67 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $41.88 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.24 | 2019-2021 | |
| Genentech USA, INC. | $30.50 | 2019-2021 | |
| Shire North American Group INC | $29.73 | 2019 | |
| Amgen INC. | $28.24 | 2019 | |
| Ironshore Pharmaceuticals INC. | $26.69 | 2019 | |
| Titan Spine, LLC | $24.22 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.98 | 2021 | |
| Metuchen Pharmaceuticals | $20.43 | 2019 | |
| Assertio Therapeutics, INC. | $19.01 | 2020 | |
| Cardiovascular Systems INC. | $16.93 | 2019 | |
| Eisai INC. | $15.40 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2021 | |
| Exact Sciences Corporation | $13.16 | 2023 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $12.12 | 2021 | |
| Amneal Pharmaceuticals LLC | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shi Tze Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.